(McKesson Corporation)

	MCK latest price $165.2000 (0.3%) ($163.6400 - $165.7300) on Tue. Jul. 11, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.6% (three month average)
RSI	65
Latest Price	$165.2000(0.3%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	MCK advances 0.1% a day on average for past five trading days.
Weekly Trend	MCK declines -0.1% a week on average for past two weeks.
Market Behavior	Normal for large cap. Growth stock rally for small cap.
Correlated ETFs	Broad market will support MCK advance at 0% a week (0% probability)   XLV(58%)    IVE(56%)    IWD(55%)    VYM(55%)    SDY(54%)
Factors Impacting MCK price	MCK will decline at least -0.8% in a week (0% probabilities).   TLT(-22%)    VIXM(-15%)    GDXJ(-9%)    UUP(-8%)    TIP(-8%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.8% (StdDev 1.6%)
Hourly BBV	0 ()
Intraday Trend	0.1%

5 Day Moving Average	$164.59(0.37%)
10 Day Moving Average	$164.87(0.2%)
20 Day Moving Average	$164.26(0.57%)
To recent high	-1.4%
To recent low	22.4%
Market Cap	$26.794b

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

getNextHourMoveProbability failed